アトピー性皮膚炎治療の世界市場:産業分析および機会分析

◆英語タイトル:Atopic Dermatitis Treatment Market - Global Industry Analysis and Opportunity Assessment, 2019-2029
◆商品コード:FMI20JA097
◆発行会社(リサーチ会社):Future Market Insights
◆発行日:2019年10月14日
◆ページ数:191
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Individual Price(1名様閲覧用)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
Corporate Price(同一法人内共有可)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Future Market Insights社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査はアトピー性皮膚炎治療について、エグゼクティブサマリー、市場概要、市場背景、市場状況、薬別(コルチコステロイド、カルシニューリン阻害剤、免疫抑制剤、生物学的療法、PDE-4阻害剤)分析、管理モード別(局所、経口、注射)分析、流通経路別(病院薬局、小売薬局、オンライン薬局、ドラッグストア、通信販売薬局)分析、地域別分析、競合分析、調査手法に区分して掲載しています。
・エグゼクティブサマリー
・市場概要
・市場背景
・市場状況
・アトピー性皮膚炎治療の世界市場:薬別(コルチコステロイド、カルシニューリン阻害剤、免疫抑制剤、生物学的療法、PDE-4阻害剤)
・アトピー性皮膚炎治療の世界市場:管理モード別(局所、経口、注射)
・アトピー性皮膚炎治療の世界市場:流通経路別(病院薬局、小売薬局、オンライン薬局、ドラッグストア、通信販売薬局)
・アトピー性皮膚炎治療の世界市場:地域別
・競合分析
・調査手法
【レポートの概要】

A recent market study published by Future Market Insights (FMI) on the atopic dermatitis treatment includes global industry analysis 2014-2018 & opportunity assessment 2019-2029, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the atopic dermatitis treatment, the growth prospects of the market are obtained with maximum precision.

Chapter 01 – Executive Summary

The report initiates with the executive summary of the atopic dermatitis treatment, which includes a summary of key findings and statistics of the market. It also includes demand & supply-side trends pertaining to the atopic dermatitis treatment.

Chapter 02 – Market Overview

Readers can find the definition and a detailed segmentation of the atopic dermatitis treatment in this chapter, which will help them understand the basic information about the atopic dermatitis treatment.

Chapter 03 – Market Background

This chapter explains the key macroeconomic factors, drivers, restraints, trends and opportunity analysis that are expected to influence the growth of the atopic dermatitis treatment over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.

Chapter 04 – Market Context

This section includes the premium insights such as regulatory scenario, disease epidemiology and parent market analysis. This section helps readers understand the key factors associated with the atopic dermatitis treatment market.

Chapter 05 – Global Atopic Dermatitis Treatment Demand Analysis 2014-2018 & Opportunity Assessment 2019-2029

This section explains the global market value analysis and forecast for the atopic dermatitis treatment between the forecast periods of 2019-2029. This chapter includes a detailed analysis of the historical atopic dermatitis treatment market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

Chapter 06 – Global Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Drug Class

Based on drug type, the atopic dermatitis treatment market is segmented into corticosteroids, calcineurin inhibitors, immunosuppressants, biologic therapy, PDE4 inhibitor, antibiotics, antihistamines, emollients. In this chapter, readers can find information about the key trends and developments in the atopic dermatitis treatment and market attractiveness analysis based on drug type.

Chapter 07 – Global Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Mode of Administration

This chapter provides details about the atopic dermatitis treatment based on mode of administration, and has been classified into oral, topical and injectable. In this chapter, readers can understand the market attractiveness analysis based on mode of administration.

Chapter 08 – Global Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Distribution Channel

This chapter provides details about the atopic dermatitis treatment market based on distribution channel, and has been classified into hospital pharmacies, retail pharmacies, online pharmacies, drug stores, mail order pharmacies, dermatological clinics. In this chapter, readers can understand the market attractiveness analysis based on distribution channel.

Chapter 09 – Global Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Region

This chapter explains how the atopic dermatitis treatment market will grow across various geographic regions such as North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East & Africa (MEA).

Chapter 10 – North America Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter includes a detailed analysis of the growth of the North America atopic dermatitis treatment market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the pricing analysis, regional trends, and market growth based on the application and countries in North America.

Chapter 11 – Latin America Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides the growth scenario of atopic dermatitis treatment market in Latin American countries such as Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.

Chapter 12 – Western Europe Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

Important growth prospects of the atopic dermatitis treatment market based on its end users in several countries such as Germany, the U.K., France, Spain, Italy, Russia, BENELUX, and the Rest of Europe are included in this chapter.

Chapter 13 – Eastern Europe Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

In this chapter, Russia, Poland & Rest of Eastern Europe countries are the prominent countries in the Eastern Europe region that are the prime subjects of assessment to obtain the growth prospects of the Eastern Europe atopic dermatitis treatment market. Readers can find detailed information about the growth parameters of the Eastern Europe atopic dermatitis treatment market during the forecast period of 2019-2029.

Chapter 14 – Asia pacific excluding Japan Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter highlights the growth of the atopic dermatitis treatment in Asia pacific excluding Japan by focusing on China, India, Australia & New Zealand, ASEAN and rest of APEJ. This section also help readers understand the key factors that are responsible for the growth of the atopic dermatitis treatment market in the APEJ region.

Chapter 15 – Japan Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter highlights the growth of the atopic dermatitis treatment in Japan. This section also help readers understand the key factors that are responsible for the growth of the atopic dermatitis treatment market in Japan.

Chapter 16 – MEA Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides information about how the atopic dermatitis treatment market will grow in major countries in the MEA region such as GCC Countries, South Africa, Turkey, Northern Africa and the Rest of MEA, during the forecast period of 2019-2029.

Chapter 17 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the atopic dermatitis treatment market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Novartis, Bayer, Allergan, Sanofi and among others.

Chapter 18 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the atopic dermatitis treatment report.

Chapter 19 – Research Methodology

This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the atopic dermatitis treatment.

【レポートの目次】

1. Executive Summary

1.1. Market Outlook

1.2. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Macro-Economic Factors

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity Analysis

3.1.4. Trends

4. Market Context

4.1. Global Atopic Dermatitis Treatment Market Size (US$ Mn) and Forecast

4.2. Global Epidemiology of Atopic Dermatitis

4.3. Global Atopic Dermatitis Treatment Market Opportunity Analysis

4.4. Key Regulations and Guidelines

5. Global Atopic Dermatitis Treatment Market (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

5.2.3. Market Value Comparison

6. Global Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Class

6.1. Introduction / Key Findings

6.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2014-2018

6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2019 – 2029

6.3.1. Corticosteroids

6.3.2. Calcineurin Inhibitors

6.3.3. Immunosuppressant

6.3.4. Biologic Therapy

6.3.5. PDE-4 Inhibitor

6.3.6. Antibiotics

6.3.7. Antihistamines

6.3.8. Emollients

6.4. Market Attractiveness Analysis By Drug Class

7. Global Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Mode of Administration

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Mode of Administration, 2014-2018

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Mode of Administration, 2019 – 2029

7.3.1. Topical

7.3.2. Oral

7.3.3. Injectable

7.4. Market Attractiveness Analysis By Mode of Administration

8. Global Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 – 2029

8.3.1. Hospital Pharmacies

8.3.2. Retail Pharmacies

8.3.3. Online Pharmacies

8.3.4. Drug Stores

8.3.5. Mail Order Pharmacies

8.3.6. Dermatology Clinics

8.4. Market Attractiveness Analysis By Distribution Channel

9. Global Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Region Type

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018

9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029

9.3.1. North America

9.3.2. Latin America

9.3.3. Western Europe

9.3.4. Eastern Europe

9.3.5. Asia-Pacific Excluding Japan

9.3.6. Japan

9.3.7. Middle East and Africa

9.4. Market Attractiveness Analysis By Region

10. North America Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

10.3.1. By Country

10.3.1.1. U.S.

10.3.1.2. Canada

10.3.2. By Drug Class

10.3.3. By Mode of Administration

10.3.4. By Distribution Channel

10.4. Market Attractiveness Analysis

10.4.1. By Country

10.4.2. By Drug Class

10.4.3. By Mode of Administration

10.4.4. By Distribution Channel

11. Latin America Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

11.3.1. By Country

11.3.1.1. Mexico

11.3.1.2. Brazil

11.3.1.3. Rest of Latin America

11.3.2. By Drug Class

11.3.3. By Mode of Administration

11.3.4. By Distribution Channel

11.4. Market Attractiveness Analysis

11.4.1. By Country

11.4.2. By Drug Class

11.4.3. By Mode of Administration

11.4.4. By Distribution Channel

12. Western Europe Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

12.3.1. By Country

12.3.1.1. Germany

12.3.1.2. Italy

12.3.1.3. France

12.3.1.4. U.K.

12.3.1.5. Spain

12.3.1.6. BENELUX

12.3.1.7. Nordic

12.3.1.8. Rest of Western Europe

12.3.2. By Drug Class

12.3.3. By Mode of Administration

12.3.4. By Distribution Channel

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Drug Class

12.4.3. By Mode of Administration

12.4.4. By Distribution Channel

13. Eastern Europe Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

13.3.1. By Country

13.3.1.1. Germany

13.3.1.2. Italy

13.3.1.3. France

13.3.1.4. U.K.

13.3.1.5. Spain

13.3.1.6. BENELUX

13.3.1.7. Nordic

13.3.1.8. Rest of Western Europe

13.3.2. By Drug Class

13.3.3. By Mode of Administration

13.3.4. By Distribution Channel

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Drug Class

13.4.3. By Mode of Administration

13.4.4. By Distribution Channel

14. APEJ Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

14.3.1. By Country

14.3.1.1. China

14.3.1.2. India

14.3.1.3. Australia & New Zealand

14.3.1.4. ASEAN

14.3.1.5. Rest of APEJ

14.3.2. By Drug Class

14.3.3. By Mode of Administration

14.3.4. By Distribution Channel

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Drug Class

14.4.3. By Mode of Administration

14.4.4. By Distribution Channel

15. Japan Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

15.3.1. By Drug Class

15.3.2. By Mode of Administration

15.3.3. By Distribution Channel

15.4. Market Attractiveness Analysis

15.4.1. By Drug Class

15.4.2. By Mode of Administration

15.4.3. By Distribution Channel

16. Middle East and Africa Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

16.3.1. By Country

16.3.1.1. GCC Countries

16.3.1.2. Northern Africa

16.3.1.3. South Africa

16.3.1.4. Turkey

16.3.1.5. Rest of MEA

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Drug Class

16.4.3. By Mode of Administration

17. Competition Analysis

17.1. Competition Dashboard

17.2. Competition Deep Dive

17.2.1. Sanofi S.A.

17.2.1.1. Overview

17.2.1.2. Product Portfolio

17.2.1.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.1.4. Sales Footprint

17.2.1.5. Strategy Overview

17.2.1.5.1. Marketing Strategy

17.2.1.5.2. Product Strategy

17.2.1.5.3. Mode of Administration Strategy

17.2.2. Galderma S.A

17.2.2.1. Overview

17.2.2.2. Product Portfolio

17.2.2.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.2.4. Sales Footprint

17.2.2.5. Strategy Overview

17.2.2.5.1. Marketing Strategy

17.2.2.5.2. Product Strategy

17.2.2.5.3. Mode of Administration Strategy

17.2.3. Allergan Plc.

17.2.3.1. Overview

17.2.3.2. Product Portfolio

17.2.3.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.3.4. Sales Footprint

17.2.3.5. Strategy Overview

17.2.3.5.1. Marketing Strategy

17.2.3.5.2. Product Strategy

17.2.3.5.3. Mode of Administration Strategy

17.2.4. Novartis AG

17.2.4.1. Overview

17.2.4.2. Product Portfolio

17.2.4.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.4.4. Sales Footprint

17.2.4.5. Strategy Overview

17.2.4.5.1. Marketing Strategy

17.2.4.5.2. Product Strategy

17.2.4.5.3. Mode of Administration Strategy

17.2.5. Bristol-Meyer Squibb

17.2.5.1. Overview

17.2.5.2. Product Portfolio

17.2.5.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.5.4. Sales Footprint

17.2.5.5. Strategy Overview

17.2.5.5.1. Marketing Strategy

17.2.5.5.2. Product Strategy

17.2.5.5.3. Mode of Administration Strategy

17.2.6. Bayer AG

17.2.6.1. Overview

17.2.6.2. Product Portfolio

17.2.6.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.6.4. Sales Footprint

17.2.6.5. Strategy Overview

17.2.6.5.1. Marketing Strategy

17.2.6.5.2. Product Strategy

17.2.6.5.3. Mode of Administration Strategy

17.2.7. Mylan Pharmaceuticals Inc.

17.2.7.1. Overview

17.2.7.2. Product Portfolio

17.2.7.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.7.4. Sales Footprint

17.2.7.5. Strategy Overview

17.2.7.5.1. Marketing Strategy

17.2.7.5.2. Product Strategy

17.2.7.5.3. Mode of Administration Strategy

17.2.8. Astellas Pharma Inc.

17.2.8.1. Overview

17.2.8.2. Product Portfolio

17.2.8.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.8.4. Sales Footprint

17.2.8.5. Strategy Overview

17.2.8.5.1. Marketing Strategy

17.2.8.5.2. Product Strategy

17.2.8.5.3. Mode of Administration Strategy

17.2.9. Anacor Pharmaceuticals, Inc.

17.2.9.1. Overview

17.2.9.2. Product Portfolio

17.2.9.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.9.4. Sales Footprint

17.2.9.5. Strategy Overview

17.2.9.5.1. Marketing Strategy

17.2.9.5.2. Product Strategy

17.2.9.5.3. Mode of Administration Strategy

17.2.10. Regeneron Pharmaceuticals, Inc.

17.2.10.1. Overview

17.2.10.2. Product Portfolio

17.2.10.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.10.4. Sales Footprint

17.2.10.5. Strategy Overview

17.2.10.5.1. Marketing Strategy

17.2.10.5.2. Product Strategy

17.2.10.5.3. Mode of Administration Strategy

17.2.11. Bausch Health Inc.

17.2.11.1. Overview

17.2.11.2. Product Portfolio

17.2.11.3. Profitability by Market Segments (Product/Mode of Administration/Region)

17.2.11.4. Sales Footprint

17.2.11.5. Strategy Overview

17.2.11.5.1. Marketing Strategy

17.2.11.5.2. Product Strategy

17.2.11.5.3. Mode of Administration Strategy

18. Assumptions and Acronyms Used

19. Research Methodology



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[アトピー性皮膚炎治療の世界市場:産業分析および機会分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆